Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Shiloh, R.
Zemishlany, Z.
Aizenberg, D.
and
Weizman, A.
1997.
Adición de sulpirida a la clozapina en pacientes esquizofrénicos resistentes al tratamiento: un estudio preliminar de una serie clínica.
European psychiatry (Ed. Española),
Vol. 4,
Issue. 7,
p.
476.
Shiloh, Roni
Zemishlany, Zvi
Aizenberg, Dov
Radwan, Marguerite
Schwartz, Bruria
Dorfman-Etrog, Pnina
Modai, Ilan
Khaikin, Marina
and
Weizman, Abraham
1997.
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
569.
Raskin, Sergey
Durst, Rimona
Katz, Gregory
and
Zislin, Josef
2000.
Olanzapine and Sulpiride: A Preliminary Study of Combination/Augmentation in Patients With Treatment-Resistant Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 20,
Issue. 5,
p.
500.
Lerner, Vladimir
Libov, Igor
Kotler, Moshe
and
Strous, Rael D
2004.
Combination of “atypical” antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 28,
Issue. 1,
p.
89.
PATRICK, VIJAYALAKSHMY
LEVIN, ELIZABETH
and
SCHLEIFER, STEVEN
2005.
Antipsychotic Polypharmacy: Is There Evidence for its Use?.
Journal of Psychiatric Practice,
Vol. 11,
Issue. 4,
p.
248.
Zink, M.
and
Dressing, H.
2005.
Clozapin-Augmentation mit atypischen Antipsychotika.
Der Nervenarzt,
Vol. 76,
Issue. 9,
p.
1092.
Kontaxakis, Vassilis P.
Ferentinos, Panayotis P.
Havaki-Kontaxaki, Beata J.
and
Roukas, Dimitris K.
2005.
Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
European Psychiatry,
Vol. 20,
Issue. 5-6,
p.
409.
Kontaxakis, Vassilis P.
Ferentinos, Panayotis P.
Havaki-Kontaxaki, Beata J.
and
Roukas, Dimitris K.
2006.
Ensayos de aumento controlados distribuidos al azar en pacientes esquizofrénicos resistentes a la clozapina: una revisión crítica.
European psychiatry (Ed. Española),
Vol. 13,
Issue. 1,
p.
17.
Mouaffak, Fay??al
Tranulis, Constantin
Gourevitch, Raphael
Poirier, Marie-France
Douki, Saida
Oli??, Jean-Pierre
L??o, Henri
and
Gourion, David
2006.
Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia.
Clinical Neuropharmacology,
Vol. 29,
Issue. 1,
p.
28.
Paton, Carol
Whittington, Craig
and
Barnes, Thomas R.
2007.
Augmentation With a Second Antipsychotic in Patients With Schizophrenia Who Partially Respond to Clozapine.
Journal of Clinical Psychopharmacology,
Vol. 27,
Issue. 2,
p.
198.
Pandurangi, Anand K.
and
Dalkilic, Alican
2008.
Polypharmacy With Second-Generation Antipsychotics: A Review of Evidence.
Journal of Psychiatric Practice,
Vol. 14,
Issue. 6,
p.
345.
Tranulis, Constantin
Skalli, Leila
Lalonde, Pierre
Nicole, Luc
and
Stip, Emmanuel
2008.
Benefits and Risks of Antipsychotic Polypharmacy.
Drug Safety,
Vol. 31,
Issue. 1,
p.
7.
Lamia, Dellagi
Olfa, Ben Azouz
Ines, Johnson
and
Karim, Tabbane
2009.
Resistant-schizophrenia after discontinuation of clozapine: Report of two cases.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 33,
Issue. 8,
p.
1553.
Friedman, Joseph I
Lindenmayer, Jean-Pierre
Alcantara, Frances
Bowler, Stephanie
Parak, Mohan
White, Leonard
Iskander, Adel
Parrella, Michael
Adler, David N
Tsopelas, Nicholas D
Tsai, Wei-Yann
Novakovick, Vladan
Harvey, Philip D
and
Davis, Kenneth L
2011.
Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy.
Neuropsychopharmacology,
Vol. 36,
Issue. 6,
p.
1289.
Van Sant, Scott P
and
Buckley, Peter F
2011.
Pharmacotherapy for treatment-refractory schizophrenia.
Expert Opinion on Pharmacotherapy,
Vol. 12,
Issue. 3,
p.
411.
Misawa, Fuminari
Yasuo, Fujii
Okumura, Yasuyuki
and
Ito, Hiroto
2013.
Polypharmacy in Psychiatry Practice, Volume II.
p.
145.
Lerner, Vladimir
and
Miodownik, Chanoch
2013.
Polypharmacy in Psychiatry Practice, Volume II.
p.
109.
Ortiz-Orendain, Javier
Castiello-de Obeso, Santiago
Colunga-Lozano, Luis Enrique
Hu, Yue
Maayan, Nicola
and
Adams, Clive E
2017.
Antipsychotic combinations for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2017,
Issue. 10,
Grover, Sandeep
and
Sahoo, Swapnajeet
2019.
Treatment of Clozapine Nonresponders.
Current Treatment Options in Psychiatry,
Vol. 6,
Issue. 1,
p.
32.
Campana, Mattia
Falkai, Peter
Siskind, Dan
Hasan, Alkomiet
and
Wagner, Elias
2021.
Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis.
Schizophrenia Research,
Vol. 228,
Issue. ,
p.
218.
Comments
No Comments have been published for this article.